Globitair

Stock market

Moderna shares sink after leaked cancer data missed expectations

Financial TimesUnited States of America

Moderna shares sink after leaked cancer data missed expectations

Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations

Read the full story at Financial TimesOpen in the live monitor

On the map

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America

More on Stock market